{
    "q": [
        {
            "docid": "4421942_3",
            "document": "TetR . Tetracycline (tc) is a broad family of antibiotics to which bacteria have evolved resistance. Tc normally kills bacteria by binding to the bacterial ribosome and halting protein synthesis. The expression of tc resistance genes is regulated by Tet Repressor Protein. More specifically, TetR represses the expression of TetA, a membrane protein that pumps out substances toxic to the bacteria, by binding the TetA operator. In tc resistant bacteria, TetA will pump out tc before it can bind to the ribosome. Therefore, TetR may have an important role in helping scientists to better understand mechanisms of antibiotic resistance and how to treat antibiotic resistant bacteria. TetR is one of many proteins in the TetR protein family, which is so named because TetR is the most well characterized member.",
            "score": 87.01418995857239
        },
        {
            "docid": "205627_18",
            "document": "Drug resistance . For antibiotic resistance, which represents a widespread problem nowadays, drugs designed to block the mechanisms of bacterial antibiotic resistance are used. For example, bacterial resistance against beta-lactam antibiotics (such as penicillins and cephalosporins) can be circumvented by using antibiotics such as nafcillin that are not susceptible to destruction by certain beta-lactamases (the group of enzymes responsible for breaking down beta-lactams). Beta-lactam bacterial resistance can also be dealt with by administering beta-lactam antibiotics with drugs that block beta-lactamases such as clavulanic acid so that the antibiotics can work without getting destroyed by the bacteria first. Recently, researchers have recognized the need for new drugs that inhibit bacterial efflux pumps, which cause resistance to multiple antibiotics such as beta-lactams, quinolones, chloramphenicol, and trimethoprim by sending molecules of those antibiotics out of the bacterial cell. Sometimes a combination of different classes of antibiotics may be used synergistically; that is, they work together to effectively fight bacteria that may be resistant to one of the antibiotics alone.",
            "score": 77.08903706073761
        },
        {
            "docid": "541592_10",
            "document": "Broad-spectrum antibiotic . After continued exposure to an antibiotic, bacteria may develop changes in their structure or function that make them resistant to the antibiotic. These resistant organisms will live, while the susceptible organisms will die, leaving the population of bacteria entirely resistant to a given antibiotics. For example, after the discovery of penicillin and its subsequent use to treat bacterial infections, bacteria were found to have begun producing an enzyme, penicillinase, which rendered the penicillin molecule inactive. In response to this newly-acquired resistance, newer penicillins were produced that could not be de-activated by penicillinases. This cycle of bacteria evolving resistance to antibiotics and necessitating the development of new antibiotics has been referred to as a \"bacterial arms race.\"",
            "score": 87.96702575683594
        },
        {
            "docid": "4427_3",
            "document": "Beta-lactam . The \u03b2-lactam ring is part of the core structure of several antibiotic families, the principal ones being the penicillins, cephalosporins, carbapenems, and monobactams, which are, therefore, also called \u03b2-lactam antibiotics. Nearly all of these antibiotics work by inhibiting bacterial cell wall biosynthesis. This has a lethal effect on bacteria, although any given bacteria population will typically contain a subgroup that is resistant to \u03b2-lactam antibiotics. Bacterial resistance occurs as a result of the expression of one of many genes for the production of \u03b2-lactamases, a class of enzymes that break open the \u03b2-lactam ring. More than 1,800 different \u03b2-lactamase enzymes have been documented in various species of bacteria. These enzymes vary widely in their chemical structure and catalytic efficiencies. When bacterial populations have these resistant subgroups, treatment with \u03b2-lactam can result in the resistant strain becoming more prevalent and therefore more virulent. \u03b2-lactam derived antibiotics can be considered as one of the most important antibiotic classes but prone to clinical resistance. \u03b2-lactam exhibits its antibiotic properties by imitating the naturally occurring d-Ala-d-Ala substrate for the group of enzymes known as penicillin-binding proteins (PBP), which have as function to cross-link the peptidoglycan part of the cell wall of the bacteria.",
            "score": 68.97156703472137
        },
        {
            "docid": "12815929_2",
            "document": "\u0392-Lactamase inhibitor . Beta-lactamases are a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. They act by breaking the beta-lactam ring that allows penicillin-like antibiotics to work. Strategies for combating this form of resistance have included the development of new beta-lactam antibiotics that are more resistant to cleavage and the development of the class of enzyme inhibitors called beta-lactamase inhibitors. Although \u03b2-lactamase inhibitors have little antibiotic activity of their own, they prevent bacterial degradation of beta-lactam antibiotics and thus extend the range of bacteria the drugs are effective against.",
            "score": 56.04358243942261
        },
        {
            "docid": "1914_3",
            "document": "Antimicrobial resistance . Resistance arises through one of three mechanisms: natural resistance in certain types of bacteria, genetic mutation, or by one species acquiring resistance from another. All classes of microbes can develop resistance. Fungi develop antifungal resistance. Viruses develop antiviral resistance. Protozoa develop antiprotozoal resistance, and bacteria develop antibiotic resistance. Resistance can appear spontaneously because of random mutations. However, extended use of antimicrobials appears to encourage mutations which can render antimicrobials ineffective. Preventive measures include only using antibiotics when needed, thereby stopping misuse of antibiotics or antimicrobials. Narrow-spectrum antibiotics are preferred over broad-spectrum antibiotics when possible, as effectively and accurately targeting specific organisms is less likely to cause resistance. For people who take these medications at home, education about proper use is essential. Health care providers can minimize spread of resistant infections by use of proper sanitation and hygiene, including handwashing and disinfecting between patients, and should encourage the same of the patient, visitors, and family members. Rising drug resistance is caused mainly by use of antimicrobials in humans and other animals, and spread of resistant strains between the two. Growing resistance has also been linked to dumping of inadequately treated effluents from the pharmaceutical industry, especially in countries where bulk drugs are manufactured. Antibiotics increase selective pressure in bacterial populations, causing vulnerable bacteria to die; this increases the percentage of resistant bacteria which continue growing. Even at very low levels of antibiotic, resistant bacteria can have a growth advantage and grow faster than vulnerable bacteria. With resistance to antibiotics becoming more common there is greater need for alternative treatments. Calls for new antibiotic therapies have been issued, but new drug development is becoming rarer.",
            "score": 79.9481440782547
        },
        {
            "docid": "9028799_58",
            "document": "Bacteria . Bacterial infections may be treated with antibiotics, which are classified as bacteriocidal if they kill bacteria, or bacteriostatic if they just prevent bacterial growth. There are many types of antibiotics and each class inhibits a process that is different in the pathogen from that found in the host. An example of how antibiotics produce selective toxicity are chloramphenicol and puromycin, which inhibit the bacterial ribosome, but not the structurally different eukaryotic ribosome. Antibiotics are used both in treating human disease and in intensive farming to promote animal growth, where they may be contributing to the rapid development of antibiotic resistance in bacterial populations. Infections can be prevented by antiseptic measures such as sterilising the skin prior to piercing it with the needle of a syringe, and by proper care of indwelling catheters. Surgical and dental instruments are also sterilised to prevent contamination by bacteria. Disinfectants such as bleach are used to kill bacteria or other pathogens on surfaces to prevent contamination and further reduce the risk of infection.",
            "score": 101.97394752502441
        },
        {
            "docid": "40364158_47",
            "document": "Antibiotic use in livestock . Around 70% of all antibiotics administered are used for livestock. Some drugs are used in livestock feed to prevent illnesses and or increase growth rates, but others are used as injection to treat illnesses to prevent death. The use of antibiotics in livestock can be harmful to humans because it can create an antibiotic resistant bacteria in humans that can be transferred through several different ways such as: raw meats, consumption of meats, as well as ingestion through airborne bacteria. Waste from food-producing animals can also contain antibiotic-resistant bacteria and is sometimes stored in lagoons. This waste is often sprayed as fertilizer and can thus contaminate crops and water with the antibiotic-resistant bacteria. Although antibiotic use in livestock can be harmful to humans, most see it as a necessary evil to prevent disease and death in out livestock. Antibiotic resistance makes humans resistant to certain types of drugs for different diseases, as well as makes it harder for them to fight off infections.",
            "score": 78.35921907424927
        },
        {
            "docid": "37791213_2",
            "document": "Carbapenem-resistant enterobacteriaceae . Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative bacteria that are resistant to the carbapenem class of antibiotics, considered the drugs of last resort for such infections. They are resistant because they produce an enzyme called a carbapenemase that disables the drug molecule. The resistance can vary from moderate to severe. Enterobacteriaceae are common commensals and infectious agents. Experts fear CRE as the new \"superbug\". The bacteria can kill up to half of patients who get bloodstream infections. Tom Frieden, former head of the Centers for Disease Control and Prevention has referred to CRE as \"nightmare bacteria\". Types of CRE are sometimes known as KPC (Klebsiella pneumoniae carbapenemase) and NDM (New Delhi Metallo-beta-lactamase). KPC and NDM are enzymes that break down carbapenems and make them ineffective. Both of these enzymes, as well as the enzyme VIM (Verona Integron-Mediated Metallo-\u03b2-lactamase) have also been reported in Pseudomonas.",
            "score": 85.6017495393753
        },
        {
            "docid": "28331039_2",
            "document": "New Delhi metallo-beta-lactamase 1 . New Delhi metallo-beta-lactamase 1 (NDM-1) is an enzyme that makes bacteria resistant to a broad range of beta-lactam antibiotics. These include the antibiotics of the carbapenem family, which are a mainstay for the treatment of antibiotic-resistant bacterial infections. The gene for NDM-1 is one member of a large gene family that encodes beta-lactamase enzymes called carbapenemases. Bacteria that produce carbapenemases are often referred to in the news media as \"superbugs\" because infections caused by them are difficult to treat. Such bacteria are usually susceptible only to polymyxins and tigecycline.",
            "score": 66.09096717834473
        },
        {
            "docid": "5464960_45",
            "document": "Enzyme inhibitor . Drugs also are used to inhibit enzymes needed for the survival of pathogens. For example, bacteria are surrounded by a thick cell wall made of a net-like polymer called peptidoglycan. Many antibiotics such as penicillin and vancomycin inhibit the enzymes that produce and then cross-link the strands of this polymer together. This causes the cell wall to lose strength and the bacteria to burst. In the figure, a molecule of penicillin (shown in a ball-and-stick form) is shown bound to its target, the transpeptidase from the bacteria \"Streptomyces\" R61 (the protein is shown as a ribbon-diagram).",
            "score": 73.42974638938904
        },
        {
            "docid": "33032867_17",
            "document": "Discovery and development of cephalosporins . Cephalosporins must get through the bacterial cell wall in order to reach the target PBP. In comparison, it is easier to penetrate the cell wall of gram-positive bacteria than the cell wall of gram-negative bacteria. The cell wall structure of gram-positive bacteria is made routinely up by peptidoglycan which allows the passage of cephalosporin-sized molecules. The cell wall structure of gram-negative bacteria is more complex, composed of polysaccharides, lipids and proteins, and is harder to penetrate. Particles get through the outer membrane through water-filled channels, or porins, which are trans membrane proteins. During exposure to cephalosporins the bacteria can form resistance by itself or as selection of the next generation of bacteria after reproducing itself, by mutation. Bacteria species such as \"pneumococci\" and \"meningococci\" can acquire exogenous genetic material, and incorporate it into their own chromosomes which leads to antimicrobial resistance. In that manner the target PBP can be altered to have their attraction for cephalosporins and other \u03b2-lactam antibiotics lowered. The bacteria can also replace the PBP that is vulnerable to Beta-lactam antibiotics with PBP that is less vulnerable. \u03b2-lactam antibiotics can be inactivated by many types of \u03b2-lactamases, which are produced by bacteria. The enzymes hydrolyze the bond between the carbon and nitrogen atom of the \u03b2-lactam ring. There are many beta lactamases which vary in substrate specificity and host range. The enzymes active site is easily regenerated hydrolytically so it is re-usable many times, in that way can a comparatively small amount of beta-lactamases destroy a large amount of drug. Gram-positive bacteria, such as a staphylococci, have a high release of beta-lactamases into their extracellular space, where they meet the drug outside the cell wall. Gram-negative bacteria on the other hand follow a more conservative course. They secrete their beta-lactamases into the periplasmic space between the inner and outer membrane so they can't easily escape into the extracellular space, and don't have to be biosynthesized in high quantities.",
            "score": 80.19720602035522
        },
        {
            "docid": "38162533_4",
            "document": "Antimicrobials in aquaculture . The overuse of antibiotics can create antibiotic-resistant bacteria. Antibiotic-resistant bacteria can spontaneously arise when selective pressure to survive results in changes to the DNA sequence of a bacterium allowing that bacterium to survive antibiotic treatments. Because some of the same antibiotics are used to treat fish that are used to treat human disease, pathogenic bacteria causing human disease can also become resistant to antibiotics as a result of treatment of fish with antibiotics. For this reason, the overuse of antibiotics in treatment of fish aquaculture (among other agricultural uses) could create public health issues.",
            "score": 81.38406014442444
        },
        {
            "docid": "38156540_40",
            "document": "Seafood mislabelling . The overuse of antibiotics can create antibiotic-resistant bacteria. Antibiotic-resistant bacteria can spontaneously arise when selective pressure to survive results in changes to the DNA sequence of a bacteria allowing that bacteria to survive antibiotic treatments. Because some of the same antibiotics are used to treat fish that are used to treat human disease, pathogenic bacteria causing human disease can also become resistant to antibiotics as a result of treatment of fish with antibiotics. For this reason, the overuse of antibiotics in treatment of fish aquaculture (among other agricultural uses) could create public health issues.",
            "score": 84.12793755531311
        },
        {
            "docid": "5745363_5",
            "document": "Evolutionary pressure . Drug resistance in bacteria is an example of an outcome of natural selection. When a drug is used on a species of bacteria, those that cannot resist die and do not produce offspring, while those that survive potentially pass on the resistance gene to the next generation (vertical gene transmission). The resistance gene can also be passed on to one bacterium by another of a different species (horizontal gene transmission). Because of this, the drug resistance increases over generations. For example, in hospitals, environments are created where pathogens such as \"C\". \"difficile\" have developed a resistance to antibiotics. Antibiotic resistance is made worse by the misuse of antibiotics. Antibiotic resistance is encouraged when antibiotics are used to treat non-bacterial diseases, and when antibiotics are not used for the prescribed amount of time or in the prescribed dose. Antibiotic resistance may arise out of standing genetic variation in a population or de novo mutations in the population. Either pathway could lead to antibiotic resistance, which may be a form of evolutionary rescue.",
            "score": 83.39438343048096
        },
        {
            "docid": "44981660_7",
            "document": "Eleftheria terrae . \"E. terrae\"s production of teixobactin is prominent because recent tests have revealed that teixobactin binds differently than most normally used antibiotics which makes it harder for the bacteria being attacked to develop resistance. Experiments performed by Ling et al. have shown teixobactin is capable of binding to lipid precursors of peptidoglycan, which makes up part of bacterial cell walls. The results did not show any resistance to teixobactin in the organisms that were studied, including \"Staphylococcus aureus\" and \"Mycobacterium tuberculosis\". These findings indicate that teixobactin's target is not a protein, leading to the belief that the development of bacterial resistance to teixobactin is much less likely. These experiments also showed that teixobactin followed a similar mechanism of action as the antibiotic vancomycin that binds to the lipid II molecule in peptidoglycan precursors but, unlike vancomycin, teixobactin is capable of binding to modified lipid II molecules found in vancomycin resistant bacteria. Teixobactin's inhibition of peptidoglycan synthesis is further explained by Ling's finding of a buildup of undecaprenyl-N-acetylmuramic acid-pentapeptide, a crucial step in the biosynthesis of peptidoglycan. According to Ling's tests, teixobactin is capable of inhibiting peptidoglycan synthesis by binding to either lipid I, lipid II, and undecaprenyl pyrophosphate. Teixobactin also seemed to be specifically involved with peptidoglycan precursors rather than blocking enzyme activity.",
            "score": 77.43646371364594
        },
        {
            "docid": "424464_2",
            "document": "Linezolid . Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant \"Staphylococcus aureus\" (MRSA). The main uses are infections of the skin and pneumonia although it may be used for a variety of other infections including drug resistant tuberculosis. It is used either by injection into a vein or by mouth. Linezolid is a member of the oxazolidinone class of medications. When given for short periods, linezolid is a relatively safe antibiotic. It can be used in people of all ages and in people with liver disease or poor kidney function. Common side effects with short-term use include headache, diarrhea, rash, and nausea. Serious side effects may include serotonin syndrome, bone marrow suppression, and high blood lactate levels, particularly when used for more than two weeks. If used for longer periods it may cause nerve damage, including optic nerve damage, which may be irreversible. As a protein synthesis inhibitor, it affects the ability of bacteria to produce protein. This either stops growth or results in bacterial death. Although many antibiotics work this way, the exact mechanism of action of linezolid appears to be unique in that it blocks the start of protein production, rather than one of the later steps. As of 2014 bacterial resistance to linezolid has remained low. Linezolid was discovered in the mid 1990s and was approved for commercial use in 2000. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Linezolid is available as a generic medication. The wholesale cost in the developing world is about US$ 2.90 USD per day while that in the United States as of 2016 is about US$13.79 per day. It appears to be more cost-effective than alternatives such as vancomycin, mostly because of the ability to switch from intravenous use to administration by mouth sooner. The main use of linezolid is the treatment of severe infections caused by anaerobic Gram-positive bacteria that are resistant to other antibiotics; it should not be used against bacteria that are sensitive to drugs with a narrower spectrum of activity, such as penicillins and cephalosporins. In both the popular press and the scientific literature, linezolid has been called a \"reserve antibiotic\"\u2014one that should be used sparingly so that it will remain effective as a drug of last resort against potentially intractable infections.",
            "score": 88.72634756565094
        },
        {
            "docid": "21147_34",
            "document": "Natural selection . Natural selection is seen in action in the development of antibiotic resistance in microorganisms. Since the discovery of penicillin in 1928, antibiotics have been used to fight bacterial diseases. The widespread misuse of antibiotics has selected for microbial resistance to antibiotics in clinical use, to the point that the methicillin-resistant \"Staphylococcus aureus\" (MRSA) has been described as a \"superbug\" because of the threat it poses to health and its relative invulnerability to existing drugs. Response strategies typically include the use of different, stronger antibiotics; however, new strains of MRSA have recently emerged that are resistant even to these drugs. This is an evolutionary arms race, in which bacteria develop strains less susceptible to antibiotics, while medical researchers attempt to develop new antibiotics that can kill them. A similar situation occurs with pesticide resistance in plants and insects. Arms races are not necessarily induced by man; a well-documented example involves the spread of a gene in the butterfly \"Hypolimnas bolina\" suppressing male-killing activity by \"Wolbachia\" bacteria parasites on the island of Samoa, where the spread of the gene is known to have occurred over a period of just five years",
            "score": 74.07289481163025
        },
        {
            "docid": "39127620_5",
            "document": "Epimerox . No bacteria could be identified that were resistant to the compound (resistance frequency of <10). Thus, epimerox is an antibiotic with low resistance potential. Therefore, 2-epimerase is a new antibiotic target to which resistance is a rare event. 2-Epimerase was discovered as a target because it was one of the enzymes in the biosynthetic pathway for synthesizing an essential neutral polysaccharide in the cell wall of \"B. anthracis\" (Glu:Gal-\"N\"Ac:Man-\"N\"Ac at a 3:2:1 ratio). This polysaccharide is only found in \"B. anthracis\" and is the receptor for a bacteriophage lysin enzyme called PlyG, which is produced by the \u03b3-bacteriophage to release its progeny from infected \"B. anthracis\". For bacteriophage to survive they need to replicate inside a bacterial cell and release their progeny phage when they are assembled using their lysin. Since lysins from bacteriophage that infect Gram-positive bacteria must bind to a cell wall receptor to function, the enzymes have evolved over a billion years to identify substrate receptors in the bacterial cell wall that the bacteria cannot change easily. These substrates are either part of the peptidoglycan or sugars linked to it. Deletion of both 2-epimerase genes in \"B. anthracis\" is lethal to the bacterium.",
            "score": 103.4041839838028
        },
        {
            "docid": "15464966_19",
            "document": "Pathogenic bacteria . Bacterial infections may be treated with antibiotics, which are classified as bacteriocidal if they kill bacteria or bacteriostatic if they just prevent bacterial growth. There are many types of antibiotics and each class inhibits a process that is different in the pathogen from that found in the host. For example, the antibiotics chloramphenicol and tetracyclin inhibit the bacterial ribosome but not the structurally different eukaryotic ribosome, so they exhibit selective toxicity. Antibiotics are used both in treating human disease and in intensive farming to promote animal growth. Both uses may be contributing to the rapid development of antibiotic resistance in bacterial populations. Phage therapy can also be used to treat certain bacterial infections.",
            "score": 85.05351066589355
        },
        {
            "docid": "4152874_7",
            "document": "Penicillin binding proteins . There has been a great deal of research into PBPs because of their role in antibiotics and resistance. Bacterial cell wall synthesis and the role of PBPs in its synthesis is a very good target for drugs of selective toxicity because the metabolic pathways and enzymes are unique to bacteria. Resistance to antibiotics has come about through overproduction of PBPs and formation of PBPs that have low affinity for penicillins (among other mechanisms such as lactamase production). Research on PBPs has led to the discovery of new semi-synthetic \u03b2-lactams, wherein altering the side-chains on the original penicillin molecule has increased the affinity of PBPs for penicillin, and, thus, increased effectiveness in bacteria with developing resistance.",
            "score": 74.25787043571472
        },
        {
            "docid": "9236_56",
            "document": "Evolution . Adaptation may cause either the gain of a new feature, or the loss of an ancestral feature. An example that shows both types of change is bacterial adaptation to antibiotic selection, with genetic changes causing antibiotic resistance by both modifying the target of the drug, or increasing the activity of transporters that pump the drug out of the cell. Other striking examples are the bacteria \"Escherichia coli\" evolving the ability to use citric acid as a nutrient in a long-term laboratory experiment, \"Flavobacterium\" evolving a novel enzyme that allows these bacteria to grow on the by-products of nylon manufacturing, and the soil bacterium \"Sphingobium\" evolving an entirely new metabolic pathway that degrades the synthetic pesticide pentachlorophenol. An interesting but still controversial idea is that some adaptations might increase the ability of organisms to generate genetic diversity and adapt by natural selection (increasing organisms' evolvability).",
            "score": 81.6725959777832
        },
        {
            "docid": "37627534_5",
            "document": "Mary Barber (bacteriologist) . Barber's research was focused on the \"staphylococcus\" bacterium as well as various aspects of antibiotics, especially development of penicillin-resistant bacteria. Her first scientific paper was published in 1937 and concerned meningitis caused by the Listeria bacterium. In 1947, she published her best-known work, on penicillin resistance in \"staphylocci\", proving that the bacteria were becoming more resistant to the drug over time, using the new technique of phage typing. She found that this was because bacteria with mutations that caused them to synthesize a penicillin-destroying enzyme were selected during treatment with antibiotics, leading to rapid spread of a single antibiotic-resistant strain throughout the hospital. Between 1948 and 1958, her focus shifted to cross-infection by \"Staphylococcus\" in hospitals, which she found to be caused by penicilin-resistant bacteria and the nurses became nasal carriers soon after working on the wards. After she returned to BPMS (British Postgraduate Medical School) in 1958, she expanded upon this work, making a clear case for limiting antibiotic use and combining drugs for maximum effect and minimal increases in drug resistance; these studies were carried out at St. Thomas' Hospital. The policies implemented as a result of her work caused antibiotic resistance observed in the hospital to drop dramatically. After her successful publications, Barber was hired by the Medical Research Council to study semisynthetic penicillin, cephalosporin, fucidin, lincomycin, and pristinamycin. In 1963, she published \"Antibiotic and Chemotherapy\" with L. P. Garrod, an encyclopedic work on the characteristics and medical uses of various antibiotics. That same year, Barber was appointed a professor; in 1965 she was elected to the Royal College of Physicians.",
            "score": 50.209466218948364
        },
        {
            "docid": "1672551_26",
            "document": "Concentrated animal feeding operation . Antibiotics are used heavily in CAFOs to both treat and prevent illness in individual animals as well as groups. The close quarters inside CAFOs promote the sharing of pathogens between animals and thus, the rapid spread of disease. Even if their stock are not sick, CAFOs will incorporate low doses of antibiotics into feed \u201cto reduce the chance for infection and to eliminate the need for animals to expend energy fighting off bacteria, with the assumption that saved energy will be translated into growth\u201d. This practice is an example of a non-therapeutic use of antibiotics. Such antibiotic use is thought to allow animals to grow faster and bigger, consequently maximizing production for that CAFO. Regardless, the World Health Organization has recommended that the non-therapeutic use of antibiotics in animal husbandry be reevaluated, as it contributes to the overuse of antibiotics and thus the emergence of resistant bacteria that can spread to humans. When bacteria naturally occurring in the animals\u2019 environment and/or body are exposed to antibiotics, natural selection results in bacteria, who have genetic variations that protect them from the drugs, to survive and spread their advantageously resistant traits to other bacteria present in the ecosystem. This is how the problem of antimicrobial resistance increases with the continued use of antibiotics by CAFOs. This is of concern to public health because resistant bacteria generated by CAFOs can be spread to the surrounding environment and communities via waste water discharge or aerosolization of particles.",
            "score": 72.839022397995
        },
        {
            "docid": "1564401_6",
            "document": "Multiple drug resistance . Many different bacteria now exhibit multi-drug resistance, including staphylococci, enterococci, gonococci, streptococci, salmonella, as well as numerous other gram-negative bacteria and \"Mycobacterium tuberculosis\". Antibiotic resistant bacteria are able to transfer copies of DNA that code for a mechanism of resistance to other bacteria even distantly related to them, which then are also able to pass on the resistance genes and so generations of antibiotics resistant bacteria are produced. This process is called horizontal gene transfer.",
            "score": 76.42165422439575
        },
        {
            "docid": "541592_2",
            "document": "Broad-spectrum antibiotic . The term broad-spectrum antibiotic can refer to an antibiotic that acts on the two major bacterial groups, gram-positive and gram-negative, or any antibiotic that acts against a wide range of disease-causing bacteria. These medications are used when a bacterial infection is suspected but the group of bacteria is unknown (also called empiric therapy) or when infection with multiple groups of bacteria is suspected. This is in contrast to a narrow-spectrum antibiotic, which is effective against only a specific group of bacteria. Although powerful, broad-spectrum antibiotics pose specific risks, particularly the disruption of native, normal bacteria and the development of antimicrobial resistance. An example of a commonly used broad-spectrum antibiotic is ampicillin.",
            "score": 62.956472396850586
        },
        {
            "docid": "40364158_66",
            "document": "Antibiotic use in livestock . There are other bacteria as well, where research is evolving and revealing that bacterial resistance acquired through use in livestock may be contributing to disease in humans. Examples of these include Enterococcus, E. coli 0157 and Staphylococcus Aureus. In the case of foodborne illness from E.coli, though it is still not typically treated with antibiotics because of associated risk of renal failure, increasing rates of antibiotic resistant infections have been correlated with increasing virulence of the bacteria. In the case of enterococcus and staphylococcus aureus, resistant forms of both of these bacteria have resulted in greatly increasing morbidity and mortality in the US. At this point, there have been studies, though a limited number, that definitively link antibiotic use in food production to these resistance patterns in humans and further research will help to further characterize this relationship.",
            "score": 72.95406699180603
        },
        {
            "docid": "1828723_11",
            "document": "Neomycin/polymyxin B/bacitracin . The three main active ingredients in Neosporin are neomycin sulfate, polymyxin B sulfate, and bacitracin zinc.  One of the main components of Neosporin is Neomycin Sulfate which is a type of antibiotic discovered in 1949 by microbiologist Selman Waksman at Rutgers University. Neomycin is a type of aminoglycoside antibiotic that fights against Gram positive and gram negative bacteria. Neomycin is often used in order to prevent risk of bacterial infections. Aminoglycosides such as Neomycin are known for their ability to bind to RNA and to change the proteins being produced by the bacteria with little to no effect on DNA. Neomycin kills bacteria as a result of irregular protein production in the bacterial cell. When the cell can no longer produce the correct proteins, its membrane will be damaged. Like Neomycin, Polymyxin B is an antibiotic. Polymyxin B alters the bacterial cell wall causing the cellular insides to leak out resulting in cell death. This antibiotic also interferes with the production of tetrahydrofolic acid by altering an enzyme. Without the tetrahydrofolic acid, the bacteria can no longer produce proteins necessary for survival. Pramoxine is used to temporarily reduce pain from burns, insect bites, and minor cuts. It works like an anesthetic by decreasing the permeability of neuron membranes. This blocks the ability of pain neurons in the area to send signals which results in numbness.",
            "score": 99.83899426460266
        },
        {
            "docid": "40364158_64",
            "document": "Antibiotic use in livestock . There have been many studies that document antibiotic resistant bacteria in livestock, though the impact of the different bacteria in humans is still undergoing research. At this time, the most well-documented impact on humans is foodborne gastrointestinal illness. In most cases, these illnesses are mild and do not require antibiotics; though if the infectious bacteria is drug-resistant, research has shown that these bacteria have increased virulence (ability to cause disease), leading to prolonged illness. Furthermore, in approximately 10% of cases, the disease becomes severe, requiring more advanced treatments. These treatments can take the form of intravenous antibiotics, supportive care for blood infections, and hospital stays, leading to higher costs and greater morbidity with a trend toward higher mortality. Severe disease with this outcome is more common with drug-resistant bacteria. Though all people are susceptible, populations shown to be at higher risk for severe disease include children, the elderly, and those with chronic disease.",
            "score": 73.67388439178467
        },
        {
            "docid": "11074490_4",
            "document": "Enterococcus faecium . This bacterium has developed multi-drug antibiotic resistance and uses colonization and secreted factors in virulence (enzymes capable of breaking down fibrin, protein and carbohydrates to regulate adherence bacteria to inhibit competitive bacteria).\u00a0The enterococcal surface protein (Esp) allows the bacteria to aggregate and form biofilms. Additional virulence factors include aggregation substance (AS), cytosolin, and gelantinase. AS allows the microbe to bind to target cells and it facilitates the transfer of genetic material between cells.",
            "score": 62.900887966156006
        },
        {
            "docid": "722565_2",
            "document": "Ketolide . Ketolides are antibiotics belonging to the macrolide group. Ketolides are derived from erythromycin by substituting the cladinose sugar with a keto-group and attaching a cyclic carbamate group in the lactone ring. These modifications give ketolides much broader spectrum than other macrolides. Moreover, ketolides are effective against macrolide-resistant bacteria, due to their ability to bind at two sites at the bacterial ribosome as well as having a structural modification that makes them poor substrates for efflux-pump mediated resistance. Ketolides block protein synthesis by binding to ribosomal subunits and may also inhibit the formation of newly forming ribosomes. According to a recent study comparing the action of the classic macrolides erythromycin and azithromycin with ketolides, which are used to treat serious infections, the more powerful drugs (ketolides) were the more \"leaky\" in blocking the production of proteins. The researchers were surprised to discover that ketolides, which are known to be better antibiotics, allow for many more proteins to be made compared to the older, less efficient macrolides. As a result, it is now believed that allowing cells to make some proteins could be much more damaging for a microbe than not letting it make any proteins at all. The findings may point the way to better and more potent antibiotics.",
            "score": 78.94351720809937
        },
        {
            "docid": "3119987_2",
            "document": "Ampicillin/sulbactam . Ampicillin/sulbactam is a combination of the common penicillin-derived antibiotic ampicillin and sulbactam, an inhibitor of bacterial beta-lactamase. Two different forms of the drug exist. The first, developed in 1987 and marketed in the United States under the tradename Unasyn, generic only outside the United States, is an intravenous antibiotic. The second, an oral form called sultamicillin, is marketed under the trade name Ampictam outside the United States. And generic only in the United States, ampicillin/sulbactam is used to treat infections caused by bacteria resistant to beta-lactam antibiotics. Sulbactam blocks the enzyme which breaks down ampicillin and thereby allows ampicillin to attack and kill the bacteria.",
            "score": 63.228646755218506
        }
    ],
    "r": [
        {
            "docid": "48626085_9",
            "document": "Streptomyces lavendulae . Many natural compounds have led to the discovery of drugs used to treat human disease. Out of the 22,500 biologically active compounds that have been extracted from microbes, 45% are from Actinobacteria. In 1956, \"Streptomyces lavendulae\" was found to produce an antibiotic called Mitomycin C, which has been studied for its cytotoxic effects on cancer cells.",
            "score": 137.51535034179688
        },
        {
            "docid": "546406_45",
            "document": "Toll-like receptor . When microbes were first recognized as the cause of infectious diseases, it was immediately clear that multicellular organisms must be capable of recognizing them when infected and, hence, capable of recognizing molecules unique to microbes. A large body of literature, spanning most of the last century, attests to the search for the key molecules and their receptors. More than 100 years ago, Richard Pfeiffer, a student of Robert Koch, coined the term \"endotoxin\" to describe a substance produced by Gram-negative bacteria that could provoke fever and shock in experimental animals. In the decades that followed, endotoxin was chemically characterized and identified as a lipopolysaccharide (LPS) produced by most Gram-negative bacteria. This lipopolysaccharide is an integral part of the gram-negative membrane and is released upon destruction of the bacterium. Other molecules (bacterial lipopeptides, flagellin, and unmethylated DNA) were shown in turn to provoke host responses that are normally protective. However, these responses can be detrimental if they are excessively prolonged or intense. It followed logically that there must be receptors for such molecules, capable of alerting the host to the presence of infection, but these remained elusive for many years.",
            "score": 118.53511047363281
        },
        {
            "docid": "19178965_69",
            "document": "Fungus . Many species produce metabolites that are major sources of pharmacologically active drugs. Particularly important are the antibiotics, including the penicillins, a structurally related group of \u03b2-lactam antibiotics that are synthesized from small peptides. Although naturally occurring penicillins such as penicillin G (produced by \"Penicillium chrysogenum\") have a relatively narrow spectrum of biological activity, a wide range of other penicillins can be produced by chemical modification of the natural penicillins. Modern penicillins are semisynthetic compounds, obtained initially from fermentation cultures, but then structurally altered for specific desirable properties. Other antibiotics produced by fungi include: ciclosporin, commonly used as an immunosuppressant during transplant surgery; and fusidic acid, used to help control infection from methicillin-resistant \"Staphylococcus aureus\" bacteria. Widespread use of antibiotics for the treatment of bacterial diseases, such as tuberculosis, syphilis, leprosy, and others began in the early 20th century and continues to date. In nature, antibiotics of fungal or bacterial origin appear to play a dual role: at high concentrations they act as chemical defense against competition with other microorganisms in species-rich environments, such as the rhizosphere, and at low concentrations as quorum-sensing molecules for intra- or interspecies signaling. Other drugs produced by fungi include griseofulvin isolated from \"Penicillium griseofulvum\", used to treat fungal infections, and statins (HMG-CoA reductase inhibitors), used to inhibit cholesterol synthesis. Examples of statins found in fungi include mevastatin from \"Penicillium citrinum\" and lovastatin from \"Aspergillus terreus\" and the oyster mushroom. Fungi produce compounds that inhibit viruses and cancer cells. Specific metabolites, such as polysaccharide-K, ergotamine, and \u03b2-lactam antibiotics, are routinely used in clinical medicine. The shiitake mushroom is a source of lentinan, a clinical drug approved for use in cancer treatments in several countries, including Japan. In Europe and Japan, polysaccharide-K (brand name Krestin), a chemical derived from \"Trametes versicolor\", is an approved adjuvant for cancer therapy.",
            "score": 116.90166473388672
        },
        {
            "docid": "21525_44",
            "document": "Nutrition . Animal intestines contain a large population of gut flora. In humans, the four dominant phyla are Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria. They are essential to digestion and are also affected by food that is consumed. Bacteria in the large intestine perform many important functions for humans, including breaking down and aiding in the absorption of fermentable fiber, stimulating cell growth, repressing the growth of harmful bacteria, training the immune system to respond only to pathogens, producing vitamin B, and defending against some infectious diseases. \"Probiotics\" refers to the idea of deliberately consuming live bacteria in an attempt to change the bacterial population in the large intestine, to the health benefit of the host human or animal. \"Prebiotic (nutrition)\" refers to the idea that consuming a bacterial energy source such as soluble fiber could support the population of health-beneficial bacteria in the large intestine. There is not yet a scientific consensus as to health benefits accruing from probiotics or prebiotics.",
            "score": 115.94041442871094
        },
        {
            "docid": "3380832_3",
            "document": "Gonadotropin-releasing hormone antagonist . Some GnRH antagonists are similar in structure to natural GnRH (a hormone made by neurons in the hypothalamus) but that have an antagonistic effect. These GnRH antagonists are peptide molecules that are made up multiple, often synthetically produced amino acids. Others are small-molecule, non-peptide compounds. GnRH antagonists compete with natural GnRH for binding to GnRH receptors, thus decreasing or blocking GnRH action in the body.",
            "score": 115.66022491455078
        },
        {
            "docid": "10492540_13",
            "document": "Lignin-modifying enzyme . Although bacteria lack homologs to the most common fungal peroxidases (lignin peroxidase, manganese peroxidase, and versatile peroxidase), many produce dye decolourizing peroxidases (DyP-type peroxidases). Bacteria from a variety of classes express DyP peroxidases, including Gammaproteobacteria, Firmicutes, and Actinobacteria. Peroxidases depolymerize lignin by oxidation using hydrogen peroxide. Fungal peroxidases have higher oxidizing power than bacterial DyP-type peroxidases studied so far, and are able to degrade more complex lignin structures. DyP-type peroxidases have been found to work on a large range of substrates, including synthetic dyes, monophenolic compounds, lignin-derived compounds, and alcohols.",
            "score": 115.11619567871094
        },
        {
            "docid": "443416_10",
            "document": "Phagocyte . A phagocyte has many types of receptors on its surface that are used to bind material. They include opsonin receptors, scavenger receptors, and Toll-like receptors. Opsonin receptors increase the phagocytosis of bacteria that have been coated with immunoglobulin G (IgG) antibodies or with complement. \"Complement\" is the name given to a complex series of protein molecules found in the blood that destroy cells or mark them for destruction. Scavenger receptors bind to a large range of molecules on the surface of bacterial cells, and Toll-like receptors\u2014so called because of their similarity to well-studied receptors in fruit flies that are encoded by the Toll gene\u2014bind to more specific molecules. Binding to Toll-like receptors increases phagocytosis and causes the phagocyte to release a group of hormones that cause inflammation.",
            "score": 113.25028991699219
        },
        {
            "docid": "32150862_3",
            "document": "Bacterial DNA binding protein . Histone-like proteins are present in many Eubacteria, Cyanobacteria, and Archaebacteria. These proteins participate in all DNA-dependent functions; in these processes, bacterial DNA binding proteins have an architectural role, maintaining structural integrity as transcription, recombination, replication, or any other DNA-dependent process proceeds. Eukaryotic histones were first discovered through experiments in 0.4M NaCl. In these high salt concentrations, the eukaryotic histone protein is eluted from a DNA solution in which single stranded DNA is bound covalently to cellulose. Following elution, the protein readily binds DNA, indicating the protein's high affinity for DNA. Histone-like proteins were unknown to be present in bacteria until similarities between eukaryotic histones and the HU-protein were noted, particularly because of the abundancy, basicity, and small size of both of the proteins. Upon further investigation, it was discovered that the amino acid composition of HU resembles that of eukaryotic histones, thus prompting further research into the exact function of bacterial DNA binding proteins and discoveries of other related proteins in bacteria.",
            "score": 112.76366424560547
        },
        {
            "docid": "1867108_8",
            "document": "Antimetabolite . Antimetabolites may also be antibiotics, such as sulfanilamide drugs, which inhibit dihydrofolate synthesis in bacteria by competing with para-aminobenzoic acid (PABA). PABA is needed in enzymatic reactions that produce folic acid, which acts as a coenzyme in the synthesis of purines and pyrimidines, the building-blocks of DNA. Mammals do not synthesize their own folic acid so they are unaffected by PABA inhibitors, which selectively kill bacteria. Sulfanilamide drugs are not like the antibiotics used to treat infections. Instead, they work by changing the DNA inside cancer cells to keep them from growing and multiplying. Antitumor antibiotics are a class of antimetabolite drugs that are cell cycle nonspecific. They act by binding with DNA molecules and preventing RNA (ribonucleic acid) synthesis, a key step in the creation of proteins, which are necessary for cancer cell survival.",
            "score": 112.49246978759766
        },
        {
            "docid": "33071344_21",
            "document": "Discovery and development of tubulin inhibitors . Multidrug resistance is the most important limitation in anticancer therapy. It can develop in many chemically distinct compounds. Until now, several mechanisms are known to develop the resistance. The most common is production of so-called \"efflux pumps\". The pumps remove drugs from tumor cells which lead to low drug concentration in the target, below therapeutic level. Efflux is caused by P-glycoprotein called also the multidrug transporter. This protein is a product of multidrug resistance gene MDR1 and a member of family of ATP-dependent transporters (ATP-binding cassette). P-glycoprotein occurs in every organism and serves to protect the body from xenobiotics and is involved in moving nutrients and other biologically important compounds inside one cell or between cells. P-glycoprotein detects substrates when they enter the plasma membrane and bind them which causes activation of one of the ATP-binding domains. The next step is hydrolysis of ATP, which leads to a change in the shape of P-gp and opens a channel through which the drug is pumped out of the cell. Hydrolysis of a second molecule of ATP results in closing of the channel and the cycle is repeated. P-glycoprotein has affinity to hydrophobic drugs with a positive charge or electrically neutral and is often over-expressed in many human cancers. Some tumors, e.g. lung cancer, do not over-express this transporter but also are able to develop the resistance. It was discovered that another transporter MRP1 also work as the efflux pump, but in this case substrates are negatively charged natural compounds or drugs modified by glutathione, conjugation, glycosylation, sulfation and glucuronylation. Drugs can enter into a cell in few kinds of ways. Major routes are: diffusion across the plasma membrane, through receptor or transporter or by the endocytosis process. Cancer can develop the resistance by mutations to their cells which result in alterations in the surface of cells or in impaired endocytosis. Mutation can eliminate or change transporters or receptors which allows drugs to enter into the tumor cell. Other cause of drug resistance is a mutation in \u03b2 tubulin which cause alterations in binding sites and a given drug cannot be bound to its target. Tumors also change expression isoforms of tubulin for these ones, which are not targets for antimitotic drugs e.g. overexpress \u03b2III-tubulin. In addition tumor cells express other kinds of proteins and change microtubule dynamic to counteract effect of anticancer drugs.  Drug resistance can also develop due to the interruption in therapy.",
            "score": 112.05821990966797
        },
        {
            "docid": "12767994_8",
            "document": "Triclocarban . The specific mechanism of action for triclocarban's health effects on humans, like in bacteria, is unclear. Generally, triclocarban enhances the gene expression of other steroid hormones, including androgens, estrogens, and cortisol. It is hypothesized that the compound acts similar to cofactors or coactivators that modulate the activity of estrogen receptors and androgen receptors. Experiments show that triclocarban activates constitutive androstane receptor and estrogen receptor alpha both \"in vivo\" and \"in vitro\" and might have the potential to alter normal physiological homeostasis. Activation of these receptors amplifies gene expression and, in doing so, may be the mechanistic base of triclocarban's health impact on humans. However, further investigation is needed to determine whether triclocarban increases the activity of sex steroid hormones by binding to the receptors or by binding to and sensitizing the receptor coactivators.",
            "score": 111.59638214111328
        },
        {
            "docid": "553114_32",
            "document": "TATA box . Pharmaceutical companies have been designing cancer therapy drugs to target DNA in traditional methods over the years, and have proven to be successful. However, the toxicity of these drugs have pushed scientists to explore other processes related to DNA that could be targeted instead. In recent years, a collective effort has been made to find cancer-specific molecular targets, such as protein-DNA complexes, which include the TATA binding motif. Compounds that trap the protein-DNA intermediate could result in it being toxic to the cell once they encounter a DNA processing event. Example of drugs that contain such compounds include topotecan, SN-38 (topoisomerase I), doxorubicin, and mitoxantrone (topoisomerase II). Cisplatin is a compound that binds covalently to adjacent guanines in the major groove of DNA, which distorts DNA to allow access of DNA-binding proteins in the minor groove. This will destabilize the interaction between the TATA-binding protein (TBP) to the TATA box. The end result is to immobilize the TATA-binding protein (TBP) on DNA in order to down-regulate transcription initiation.",
            "score": 111.31087493896484
        },
        {
            "docid": "505869_10",
            "document": "Lac operon . Specific control of the \"lac\" genes depends on the availability of the substrate lactose to the bacterium. The proteins are not produced by the bacterium when lactose is unavailable as a carbon source. The \"lac\" genes are organized into an operon; that is, they are oriented in the same direction immediately adjacent on the chromosome and are co-transcribed into a single polycistronic mRNA molecule. Transcription of all genes starts with the binding of the enzyme RNA polymerase (RNAP), a DNA-binding protein, which binds to a specific DNA binding site, the promoter, immediately upstream of the genes. Binding of RNA polymerase to the promoter is aided by the cAMP-bound catabolite activator protein (CAP, also known as the cAMP receptor protein). However, the \"lacI\" gene (regulatory gene for \"lac\" operon) produces a protein that blocks RNAP from binding to the promoter of the operon. This protein can only be removed when allolactose binds to it, and inactivates it. The protein that is formed by the \"lacI\" gene is known as the lac repressor. The type of regulation that the \"lac\" operon undergoes is referred to as negative inducible, meaning that the gene is turned off by the regulatory factor (\"lac\" repressor) unless some molecule (lactose) is added. Because of the presence of the \"lac\" repressor protein, genetic engineers who replace the \"lacZ\" gene with another gene will have to grow the experimental bacteria on agar with lactose available on it. If they do not, the gene they are trying to express will not be expressed as the repressor protein is still blocking RNAP from binding to the promoter and transcribing the gene. Once the repressor is removed, RNAP then proceeds to transcribe all three genes (\"lacZYA\") into mRNA. Each of the three genes on the mRNA strand has its own Shine-Dalgarno sequence, so the genes are independently translated. The DNA sequence of the \"E. coli\" lac operon, the \"lacZYA\" mRNA, and the \"lacI \" genes are available from GenBank (view).",
            "score": 110.64665222167969
        },
        {
            "docid": "10139931_14",
            "document": "Pseudomonas syringae . \"P. syringae\" produces polysaccharides which allow it to adhere to the surface of plant cells. It also releases quorum sensing molecules, which allows it to sense the presence of other bacterial cells nearby. If these molecules pass a threshold level, the bacteria change their pattern of gene expression to form a biofilm and begin expression virulence-related genes. The bacteria secrete highly viscous compounds such as polysaccharides and DNA to create a protective environment in which to grow.",
            "score": 110.08370971679688
        },
        {
            "docid": "18568894_6",
            "document": "Snowy River Cave . From crusts on the cave walls, antibiotic-producing actinobacteria and some 36 strains of manganese-using bacteria have been discovered. New Mexico Institute of Mining and Technology says the organisms live in this isolated environment by chemically breaking down manganese compounds, creating reconstituted mineral byproducts in the process that may have pharmaceutical uses. Scientists anticipate new biological as well as geologic discoveries will be found.",
            "score": 109.0192642211914
        },
        {
            "docid": "22519313_15",
            "document": "Cell surface receptor . G protein-coupled receptors comprise a large protein family of transmembrane receptors. They are found only in eukaryotes. The ligands which bind and activate these receptors include: photosensitive compounds, odors, pheromones, hormones, and neurotransmitters. These vary in size from small molecules to peptides and large proteins. G protein-coupled receptors are involved in many diseases, and thus are the targets of many modern medicinal drugs.",
            "score": 108.63123321533203
        },
        {
            "docid": "31009191_10",
            "document": "Microbial cooperation . One very popular example of mutually beneficial microbial interactions involves the production of siderophores. Siderophores are iron-scavenging molecules produced by many microbial taxa, including bacteria and fungi. These molecules are known as chelating agents and play an important role in facilitating the uptake and metabolism of iron in the environment, as it normally exists in an insoluble form. In order for bacteria to access this limiting factor, cells will manufacture these molecules, and then secrete them into the extracellular space. Once released, the siderophores will sequester the iron, and form a complex, which is recognized by bacterial cell receptors. It can then be transported into the cell and reduced, making the iron metabolically accessible for the bacteria. The production of siderophores is often used as an example of mutualism as the compounds are not constricted to individual usage. As long as the organism possesses a receptor for the siderophore-Fe (III) complex, they can be taken up and utilized.",
            "score": 108.29176330566406
        },
        {
            "docid": "30239813_24",
            "document": "Bacterial phyla . The \"Actinobacteria\" is a phylum of monoderm Gram positive bacteria, many of which are notable secondary metabolite producers. There are only two phyla of monoderm Gram positive bacteria, the other being the \"Firmicutes\"; the actinobacteria generally have higher GC content so are sometimes called \"high-CG Gram positive bacteria\". Notable genera/species include \"Streptomyces\" (antibiotic production), \"Propionibacterium acnes\" (odorous skin commensal) and \"Propionibacterium freudenreichii\" (holes in Emmental)",
            "score": 108.1301498413086
        },
        {
            "docid": "106256_31",
            "document": "Allosteric regulation . Allostery is a direct and efficient means for regulation of biological macromolecule function, produced by the binding of a ligand at an allosteric site topographically distinct from the orthosteric site. Due to the often high receptor selectivity and lower target-based toxicity, allosteric regulation is also expected to play an increasing role in drug discovery and bioengineering. The AlloSteric Database (ASD, http://mdl.shsmu.edu.cn/ASD) provides a central resource for the display, search and analysis of the structure, function and related annotation for allosteric molecules. Currently, ASD contains allosteric proteins from more than 100 species and modulators in three categories (activators, inhibitors, and regulators). Each protein is annotated with detailed description of allostery, biological process and related diseases, and each modulator with binding affinity, physicochemical properties and therapeutic area. Integrating the information of allosteric proteins in ASD should allow the prediction of allostery for unknown proteins, to be followed with experimental validation. In addition, modulators curated in ASD can be used to investigate potential allosteric targets for a query compound, and can help chemists to implement structure modifications for novel allosteric drug design.",
            "score": 107.37629699707031
        },
        {
            "docid": "56731305_11",
            "document": "RNA-targeting small molecule drugs . Aside from studies involved r(CUG) repeats, other complex RNA structures have also been targeted. Pearson and coworkers discovered that a cationic porphyrin (TMPyP4) bound a G-quadruplex r(GC) and inhibited the binding of proteins to r(GC). Work by Disney and Petrucelli rationally identified small molecules that can target this repeat and affect disease biology in model cellular systems and also in patient-derive iNeurons. Further studies by Rothstein and colleagues determined that TMPyP4 could suppress r(GC)-mediated neurodegeneration in a \"Drosophila\" model. Additionally targets have been rationally identified by using a powerful seqecune-based design approach termed informal to identify dozens of bioactive small molecules that target disease causing non-coding RNA termed INFORNA. This study important showed for the first time that small molecules appear to have selectivities that are competitive with oligonucleotides with cell-permeable and medicinally optimizable small molecules. Additionally, compounds have been shown to be bioactive in diverse disease settings that ranged from breast cancer. and hepatocellular carcinoma. More recently, the Disney group further used their prediction database INFORNA to design Targaprimir-96 to target miRNA precursors in animal models of cancer, the first small molecules to do so. This compound has a nanomolar affinity for the miRNA hairpin precursor selectively over other sequences. Targaprimir-96 was further tested in cells and in mice, inhibiting tumor growth in a xenograft mouse model of triple negative breast cancer upon i.p. injection. RNA-targeting small molecule drug discovery has greatly benefitted from the available cellular models for disease. The use of cell culture in early development has become a requirement for assessing the basic efficacy of a drug candidate. Thus, more research groups have implemented these techniques in their programs. In a leading example, Al-Hashimi and coworkers identified six small molecules with high affinity for TAR of HIV-1 through a computational approach. They docked a library of small molecules onto RNA dynamic structures generated by NMR and Molecular Dynamics (MD) simulations. The hit molecules inhibited the Tat\u2014TAR interaction \"in vitro\". They arrived at lead molecule, netilmicin, that had the best selectivity for HIV-1 TAR and inhibited HIV-1 replication in cells with a low IC50. The Disney group has studied aminoglycoside derivatives in 2009 for their ability to inhibit interactions between repeat RNA and proteins. Using their prediction database INFORNA, they discovered that a compound could bind to 1 x 1 UU internal loops on an N-methyl peptide backbone. They confirmed that like other compounds that target DM1 r(CUG), they could inhibit the complex between r(CUG)-MBNL1, disrupt nuclear foci, and increase nucleocytoplasmic transport of the gene in patient-derived DM1 fibroblasts. In that study the Disney group also described several approaches to validate the RNA targets of small molecules. In the first approach termed chemical cross-linking and isolation by pull down (Chem-CLIP) and chemical cross-linking and isolation by pull down to map binding sites (Chem-CLIP-Map).",
            "score": 107.14203643798828
        },
        {
            "docid": "4110763_8",
            "document": "Extrachromosomal DNA . Linear bacterial plasmids have been identified in several species of spirochete bacteria, including members of the genus \"Borrelia\" (to which the pathogen responsible for Lyme disease belongs), several species of the gram positive soil bacteria of the genus \"Streptomyces\", and in the gram negative species \"Thiobacillus versutus\", a bacterium that oxidizes sulfur. The linear plasmids of prokarykotes are found either containing a hairpin loop or a covalently bonded protein attached to the telomeric ends of the DNA molecule. The adenine-thymine rich hairpin loops of the \"Borrelia\" bacteria range in size from 5 kilobase pairs (kb) to over 200 kb and contain the genes responsible for producing a group of major surface proteins, or antigens, on the bacteria that allow it to evade the immune response of its infected host. The linear plasmids which contain a protein that has been covalently attached to the 5\u2019 end of the DNA strands are known as invertrons and can range in size from 9 kb to over 600 kb consisting of inverted terminal repeats. The linear plasmids with a covalently attached protein may assist with bacterial conjugation and integration of the plasmids into the genome. These types of linear plasmids represent the largest class of extrachromosomal DNA as they are not only present in certain bacterial cells, but all linear extrachromosomal DNA molecules found in eukaryotic cells also take on this invertron structure with a protein attached to the 5\u2019 end.",
            "score": 106.85567474365234
        },
        {
            "docid": "12732624_3",
            "document": "Potency (pharmacology) . Affinity is how well a drug can bind to a receptor (Fast/strong binding = higher affinity). Efficacy is the relationship between receptor occupancy and the ability to initiate a response at the molecular, cellular, tissue or system level. In other words, efficacy refers to how well an action is took after the drug is bound to a receptor. In pharmacology, a high efficacy usually means that a drug has worked since the drug caused the receptor to metabolize a certain compound extremely well. Therefore, it makes sense that a drug's effectiveness, potency, is affected by how well the drug can bind to a receptor, affinity, and how it is able to cause a reaction in the receptor when bound, efficacy.",
            "score": 106.78937530517578
        },
        {
            "docid": "37220_31",
            "document": "Infection . Other microscopic procedures may also aid in identifying infectious agents. Almost all cells readily stain with a number of basic dyes due to the electrostatic attraction between negatively charged cellular molecules and the positive charge on the dye. A cell is normally transparent under a microscope, and using a stain increases the contrast of a cell with its background. Staining a cell with a dye such as Giemsa stain or crystal violet allows a microscopist to describe its size, shape, internal and external components and its associations with other cells. The response of bacteria to different staining procedures is used in the taxonomic classification of microbes as well. Two methods, the Gram stain and the acid-fast stain, are the standard approaches used to classify bacteria and to diagnosis of disease. The Gram stain identifies the bacterial groups Firmicutes and Actinobacteria, both of which contain many significant human pathogens. The acid-fast staining procedure identifies the Actinobacterial genera \"Mycobacterium\" and \"Nocardia\".",
            "score": 106.59027099609375
        },
        {
            "docid": "219865_3",
            "document": "Actinobacteria . Beyond the great interest in Actinobacteria for their soil role, much is yet to be learned about them. Although currently understood primarily as soil bacteria, they might be more abundant in fresh waters. Actinobacteria is one of the dominant bacterial phyla and contains one of the largest of bacterial genera, \"Streptomyces\". \"Streptomyces\" and other actinobacteria are major contributors to biological buffering of soils. They are also the source of many antibiotics.",
            "score": 106.36817169189453
        },
        {
            "docid": "14596980_2",
            "document": "General bacterial porin family . General bacterial porins are a family of proteins from the outer membranes of Gram-negative bacteria. The porins act as molecular filters for hydrophilic compounds. They are responsible for the 'molecular sieve' properties of the outer membrane. Porins form large water-filled channels which allow the diffusion of hydrophilic molecules into the periplasmic space. Some porins form general diffusion channels that allow any solute up to a certain size (that size is known as the exclusion limit) to cross the membrane, while other porins are specific for one particular solute and contain a binding site for that solute inside the pores (these are known as selective porins). As porins are the major outer membrane proteins, they also serve as receptor sites for the binding of phages and bacteriocins.",
            "score": 106.28456115722656
        },
        {
            "docid": "14579421_29",
            "document": "Introduction to viruses . Bacteriophages are viruses that infect bacteria and archaea. The International Committee on Taxonomy of Viruses officially recognises 28 genera of bacteriophages that belong to 11 families. They are important in marine ecology: as the infected bacteria burst, carbon compounds are released back into the environment, which stimulates fresh organic growth. Bacteriophages are useful in scientific research because they are harmless to humans and can be studied easily. These viruses can be a problem in industries that produce food and drugs by fermentation and depend on healthy bacteria. Some bacterial infections are becoming difficult to control with antibiotics, so there is a growing interest in the use of bacteriophages to treat infections in humans.",
            "score": 105.7841796875
        },
        {
            "docid": "5389714_16",
            "document": "Virulence factor . Strategies to target virulence factors and the genes encoding them have been proposed. Small molecules being investigated for their ability to inhibit virulence factors and virulence factor expression include alkaloids, flavonoids, and peptides. Experimental studies are done to characterize specific bacterial pathogens and to identify their specific virulence factors. Scientists are trying to better understand these virulence factors through identification and analysis to better understand the infectious process in hopes that new diagnostic techniques, specific antimicrobial compounds, and effective vaccines or toxoids may be eventually produced to treat and prevent infection.  There are three general experimental ways for the virulence factors to be identified: biochemically, immunologically, and genetically. For the most part, the genetic approach is the most extensive way in identifying the bacterial virulence factors. Bacterial DNA can be alter from pathogenic to non-pathogenic, random mutations may be introduce to their genome, specific genes encoding for membrane or secretory products may be identified and mutated, and genes that regulate virulence genes maybe identified.",
            "score": 105.7664566040039
        },
        {
            "docid": "1485054_17",
            "document": "Sunless tanning . A novel class of compounds has been found to stimulate melanogenesis in a mechanism that is independent from \u03b1-melanocyte-stimulating hormone (\u03b1-MSH) activation of the melanocortin 1 receptor (MC receptor). This is accomplished via small molecule inhibition of salt-inducible kinases (SIK). Inhibition of SIK increases transcription of MITF which is known to increase melanin production. Work published in Cell Reports in June 2017 by Mujahid et al. from Massachusetts General Hospital Department of Dermatology has demonstrated compounds that have efficacy when applied topically to human skin. These compounds are still however in pre-clinical stages of development. Future directions may include the incorporation of SIK-inhibitor compounds with traditional UV-blocking sunscreens to minimize UV-related DNA damage in the short term while providing longer term protection through endogenous melanin production.",
            "score": 105.66251373291016
        },
        {
            "docid": "1697945_34",
            "document": "Host\u2013guest chemistry . Where The above equation can be solved by non-linear regression analysis to obtain the value of formula_2 and formula_55 and subsequently formula_56 and formula_57 for that particular reaction. The advantages of isothermal titration calorimetry over the other commonly used techniques, apart from giving the entire set of thermodynamic parameters, are that it is more general and suited for a wide range of molecules. It is not necessary to have compounds with chromophores or UV-visible functional groups in order to monitor the binding process as the heat signal is a universal property of binding reactions. At the same time, the signal to noise ratio is pretty favorable which allows for more accurate determination of the binding constants, even under very dilute conditions. A recent example of the use of this technique was for studying the binding affinity of the protein membrane surrounding Escherichia coli to lipophilic cations used in drugs in various membrane mimetic environments. The motivation for the above study was that these membranes render the bacteria resistant to most quaternary ammonium cation based compounds which have the anti-bacterial effects. Thus an understanding of the binding phenomena would enable design of effective antibiotics for E. coli. The researchers maintained a large excess of the ligand over the protein to allowing the binding reaction to go to completion. Using the above equations the researchers proceeded to calculate formula_2, formula_55, formula_56 and formula_57 for each drug in different environments. The data indicated that the binding stoichiometry of the drug with the membrane was 1:1 with a micromolar value of formula_2. The negative values of formula_55, formula_56 and formula_57 indicated that the process was enthalpy driven with a value of 8-12 kcal/mol for each drug.",
            "score": 105.32872009277344
        },
        {
            "docid": "1581134_17",
            "document": "Estrogen receptor . In the absence of hormone, estrogen receptors are largely located in the cytosol. Hormone binding to the receptor triggers a number of events starting with migration of the receptor from the cytosol into the nucleus, dimerization of the receptor, and subsequent binding of the receptor dimer to specific sequences of DNA known as hormone response elements. The DNA/receptor complex then recruits other proteins that are responsible for the transcription of downstream DNA into mRNA and finally protein that results in a change in cell function. Estrogen receptors also occur within the cell nucleus, and both estrogen receptor subtypes have a DNA-binding domain and can function as transcription factors to regulate the production of proteins.",
            "score": 105.21918487548828
        },
        {
            "docid": "12832_3",
            "document": "G protein\u2013coupled receptor . G protein\u2013coupled receptors are found only in eukaryotes, including yeast, choanoflagellates, and animals. The ligands that bind and activate these receptors include light-sensitive compounds, odors, pheromones, hormones, and neurotransmitters, and vary in size from small molecules to peptides to large proteins. G protein\u2013coupled receptors are involved in many diseases, and are also the target of approximately 34% of all modern medicinal drugs.",
            "score": 104.80979919433594
        },
        {
            "docid": "6885984_11",
            "document": "East Kolkata Wetlands . Microbial Diversity is an integral part of biodiversity which includes bacteria, archaea, fungi, algae, protozoa and protists (Ghosh, A., 2007). East Kolkata Wetland shows an immense diversity of flora and fauna both at the macro and micro level. Microbial richness of a region is its unseen asset that needs to be explored and conserved. Soil samples collected from ECW shows the presence of various new strains of microbes which are not only ecologically important but also have commercial value (Ghosh, A., 2007). These include Actinobacteria which are responsible for the degradation of nitrophenol, nitroaromatic compounds, pesticides and herbicides; Proteobacteria related to the bioremediation of heavy metals, degradation and recycling of woody tissues of plants, oil contaminated soil and toxic compounds and nitrogen fixation along with the cyanobacters; other bacteria playing important roles in metal accumulation, oil degradation, antimicrobial compound production, enzyme production etc. (Ghosh, A., 2007).",
            "score": 104.55697631835938
        }
    ]
}